July 2, 2015 – The following post would constitute a perfect example how theragenomic and personalized medicine may help patients who carry genetic predispositions for sometimes rather debilitating and eventually fatal diseases. Thus, the U.S. Food and Drug Administration (FDA) today …

Theragenomic medicine: Orkambi approved by the FDA as a new treatment for cystic fibrosis Read more »

February 03, 2012 – From a press release by the FDA, we just learn about e new success of the principle of personalized medicine. Please read the original article below: _______________________ The U.S. Food and Drug Administration today approved Kalydeco …

Ivacaftor [Kalydeco] approved by FDA to treat the rare G551D mutant positive form of cystic fibrosis Read more »